Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Xylitol Use for Decolonization of C. Difficile in Patients With IBD [Phase 1]

View source ↗

Summary

A Phase 1 study is investigating whether xylitol can decolonize Clostridioides difficile in patients with inflammatory bowel disease. The trial status is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xylitol (xylitol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Inflammatory Bowel Diseases, Clostridioides Difficile Infection | Phase 1 | Status: NOT_YET_RECRUITING